In an interview with Applied Clinical Trials Associate Editor Don Tracy, Shakthi Kumar, chief strategy & business officer, ...

In an interview with ACT senior editor Andy Studna at SCOPE Summit, Patil, vice president, digital innovation, IQVIA, ...

I’ve got my eye on four trends – the maturation of AI-powered drug development, fierce competition in the GLP-1 space, the ...

The Artificial Intelligence Action Summit in Paris was supposed to culminate with a joint declaration on artificial ...

SCOPE Conference (Summit for Clinical Ops Executives), held last week in Orlando, FL, brought together more than 4,500 industry ...

All eyes were on French President Emmanuel Macron Sunday at the end of the first day of the Artificial Intelligence Action ...

so has its focus on AI-based clinical development. “[Clinical trials are] not only the most expensive and time-consuming part of drug discovery and development (~70% of the total cost to bring ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool ...